Tisagenlecleucel Therapy: Nursing Considerations for the Outpatient Setting

Cunningham, K; DiFilippo, H; Henes, K; Irwin, LL; Napier, E; Weber, E

Weber, E (corresponding author), Hosp Univ Penn, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.

SEMINARS IN ONCOLOGY NURSING, 2021; 37 (4):

Abstract

Objective: Tisagenlecleucel is a CD19-directed, genetically modified, autologous T-cell immunotherapy indicated for pediatric and young adult patients......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索